Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Brunetti

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cellsA Falcone, M Lencioni, I Brunetti, et al.
Oncology|January 1, 1989
Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanomaM R Sertoli, M G Bernengo, A Ardizzoni, et al.
Journal of the National Cancer Institute|November 7, 1990
Oral zidovudine, continuous-infusion fluorouracil, and oral leucovorin calcium: a phase I studyM R Posner, J W Darnowski, P Calabresi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2004
Genetic alterations in hereditary breast cancerG Cipollini, S Tommasi, A Paradiso, et al.
Oncology|October 29, 2000
Oral doxifluridine in advanced hepatocellular carcinoma: A phase II studyM Lencioni, A Falcone, G Allegrini, et al.
Oncogene|October 3, 1996
BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutationsM A Caligo, C Ghimenti, G Cipollini, et al.
Tumori|March 1, 1997
Postoperative adjuvant chemoradiotherapy for rectal cancer: analysis of acute and chronic toxicityM Bertuccelli, F Cartei, A Falcone, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2013
FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancerF Loupakis, C Cremolini, L Salvatore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-OvestP F Conte, M Bruzzone, F Carnino, et al.
Gynecologic Oncology|June 1, 1997
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord OvestM Bruzzone, A Rubagotti, A Gadducci, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cellsA Falcone, M Lencioni, I Brunetti, et al.
Oncology|January 1, 1989
Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanomaM R Sertoli, M G Bernengo, A Ardizzoni, et al.
Journal of the National Cancer Institute|November 7, 1990
Oral zidovudine, continuous-infusion fluorouracil, and oral leucovorin calcium: a phase I studyM R Posner, J W Darnowski, P Calabresi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2004
Genetic alterations in hereditary breast cancerG Cipollini, S Tommasi, A Paradiso, et al.
Oncology|October 29, 2000
Oral doxifluridine in advanced hepatocellular carcinoma: A phase II studyM Lencioni, A Falcone, G Allegrini, et al.
Oncogene|October 3, 1996
BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutationsM A Caligo, C Ghimenti, G Cipollini, et al.
Tumori|March 1, 1997
Postoperative adjuvant chemoradiotherapy for rectal cancer: analysis of acute and chronic toxicityM Bertuccelli, F Cartei, A Falcone, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2013
FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancerF Loupakis, C Cremolini, L Salvatore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-OvestP F Conte, M Bruzzone, F Carnino, et al.
Gynecologic Oncology|June 1, 1997
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord OvestM Bruzzone, A Rubagotti, A Gadducci, et al.
Pageof 4